REG - Genus - Director/PDMR Shareholding

GenusAnnouncement

12/10/2018 16:40

RNS Number : 9517D
Genus PLC
12 October 2018
 


12 October 2018
 
Genus plc
 
Director/PDMR Shareholding
 
Genus plc (LSE: GNS) announces that on 9 October 2018, conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below.  In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2018, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.
Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2018 Annual Report.
The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 9 October 2018.
 
For further information please contact:
 
Genus:
Josie Havita, Interim Deputy Company Secretary                                             Tel: +44 (0)1256 347100
 
Table A - GELT 2014 Performance Share Plan Options



1.           


Details of the person discharging managerial responsibilities / person closely associated




a.            


Name


1.    Karim Bitar
2.    Stephen Wilson
3.    Bill Christianson
4.    Nate Zwald
5.    Jerry Thompson
6.    Jonathan Lightner
7.    Angelle Rosata
8.    Dan Hartley




2.            


Reason for the notification




a.            


Position/status


1.    Chief Executive
2.    Group Finance Director
3.    Chief Operating Officer Genus PIC
4.    Chief Operating Officer Genus ABS Dairy
5.    Chief Operating Officer Genus ABS Beef
6.    Chief Scientific Officer & Head of Genus R&D
7.    Group Human Resources Director
8.    Group General Counsel & Company Secretary




b.            


Initial notification
/Amendment
 


Initial notification




3.            


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a.           


Name


Genus plc




b.           


LEI


54930022EOITNKSIGH56




4.            


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a.            


Description of the
Financial instrument, type of instrument
Identification code


Ordinary shares of 10p each.
 
 
GB0002074580




b.            


Nature of the transaction


Award of nil-cost share options granted under the Genus plc 2014 Performance Share plan over ordinary shares in Genus.
 




c.            


Price(s) and volume(s)


Numbers 1 to 8 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
 



Price(s)
 


Volume(s)




1.    2,317p


55,225




2.    2,317p


29,613




3.    2,317p


19,780




4.    2,317p


16,565




5.    2,317p


16,565




6.    2,317p


19,780




7.    2,317p


15,824




8.    2,317p


17,156



      




d.            


Aggregated information
·     Aggregated volume
·     Price
 


 
 
n/a
 




e.            


Date of the transaction


2018-10-09




f.            


Place of the transaction


London Stock Exchange, Main Market (XLON)
 



 
Table B - GELT Deferred Share Bonus Plan Options



1.   


Details of the person discharging managerial responsibilities / person closely associated




a.            


Name


1.    Karim Bitar
2.    Stephen Wilson
3.    Bill Christianson
4.    Nate Zwald
5.    Jerry Thompson
6.    Jonathan Lightner
7.    Angelle Rosata
8.    Dan Hartley



 



2.            


Reason for the notification




a.            


Position/status


1.    Chief Executive
2.    Group Finance Director
3.    Chief Operating Officer Genus PIC
4.    Chief Operating Officer Genus ABS Dairy
5.    Chief Operating Officer Genus ABS Beef
6.    Chief Scientific Officer & Head of Genus R&D
7.    Group Human Resources Director
8.    Group General Counsel & Company Secretary




b.            


Initial notification
/Amendment


Initial notification




3.            


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a.           


Name


Genus plc




b.           


LEI


54930022EOITNKSIGH56




4.            


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a.            


Description of the
Financial instrument, type of instrument
Identification code


Ordinary shares of 10p each.
 
 
GB0002074580




b.            


Nature of the transaction


Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2018.
 




c.            


Price(s) and volume(s)


Numbers 1 to 8 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
 



Price(s)
 


Volume(s)




1.    2,317p


13,956




2.    2,317p


7,559




3.    2,317p


1,816




4.    2,317p


6,823




5.    2,317p


6,777




6.    2,317p


6,529




7.    2,317p


1,849




8.    2,317p


2,029
 



  




d.            


Aggregated information
·     Aggregated volume
·     Price
 


 
 
n/a




e.            


Date of the transaction


2018-10-09




f.            


Place of the transaction


London Stock Exchange, Main Market (XLON)
 



 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUUOVRWSARAAA